Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials
Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials
Christopher Pearson, Konstantinos Charizanis, Shane Foster, Mitchell Brigell et al.
Journal
Clinical ophthalmology
Topics
Sympathectomy and Hyperhidrosis Treatments
article
Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials
Christopher Pearson, Konstantinos Charizanis, Shane Foster, Mitchell Brigell, Jay Pepose
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical ophthalmologyVol. Volume 20
Institutions
Washington University in St. Louis (US), Eye Care Associates (US), Quantum Opus (United States) (US), Pepose Vision Institute (US)